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Purpose. This study examines the effects of fundus fluorescein angiography (FFA) procedure on ocular pulse amplitude (OPA)
and intraocular pressure (IOP).Materials and Methods. Sixty eyes of 30 nonproliferative diabetic retinopathy patients (15 males, 15
females) were included in this cross-sectional case series. IOP andOPAweremeasured with the Pascal dynamic contour tonometer
before and after 5 minutes of intravenous fluorescein dye injection. Results. Pre-FFA mean OPA value was 3.05 ± 1.36mmHg and
post-FFA mean OPA value was 2.93 ± 1.28mmHg (𝑃 = 0.071). Pre-FFA mean IOP value was 17.97 ± 1.99mmHg and post-FFA
mean IOP value was 17.81 ± 2.22mmHg (𝑃 = 0.407). Conclusion. Although both mean OPA and IOP values were decreased after
FFA procedure, the difference was not statistically significant. This clinical trial is registered with Australian New Zealand Clinical
Trials Registry number ACTRN12613000433707.
1. Introduction
Fundus fluorescein angiography (FFA) is a procedure for the
examination of chorioretinal circulation. It can be used to
confirm the diagnosis, monitor the progress of posterior
segment diseases, and assess the efficacy of certain treat-
ments like laser photocoagulation and intravitreal injections.
Although FFA is a safe procedure, some serious complica-
tions like allergic skin rash and anaphylaxis could be seen
rarely [1].The effect of fluorescentmolecule or FFAprocedure
on choroidal circulation is not known much.
The dynamic contour tonometry (DCT) is a noninvasive
and direct intraocular pressure (IOP) measuring device and
is considered to accurately measure the IOP independent of
the corneal thickness or corneal elasticity [2]. It also provides
a continuous examination of the IOP and measures ocular
pulse amplitude (OPA)which is accepted as an indirectmeas-
urement of the choroidal blood flow [3].
TheOPA is generally considered as the difference between
systolic and diastolic values of the pulsatile IOP. It gives us an
opinion about the choroidal blood flow corresponding with
the heart pulse as a function of time [4]. Choroidal circulation
has a vital role in ocular physiology and may be affected in
various ocular and systemic diseases [5, 6].
FFA is an imaging procedure using fluorescence ability,
and it has been thought to have little or no effect on ocular
physiology. The rationale of this study was that fluorescein
sodium passes freely through the choroidal vessels into
the extravasal space and this would have an influence on
choroidal blood flows, either by an osmotic effect or a hemo-
rheological effect. Also, influence of fluorescein sodium on
the erythrocyte aggregation was shown in the past literature,
which might be related with alterations in retina-choroidal
microcirculation [7]. Although it was not possible to examine
the tissue pathology in this study, we wanted to reveal the
effects of FFA procedure on eye in terms of IOP and OPA.
2. Materials and Method
This study was a prospective cross-sectional case series and
involved 60 eyes of 30 patients. The study was conducted
in accordance with the ethical standards of Declaration
of Helsinki and was approved by the Institutional Ethical
Committee.
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2.1. Study Population. All of the eyes had nonproliferative
diabetic retinopathy (NPDRP).The diagnosis of NPDRP was
based on indirect retinoscopy and fundus fluorescein angiog-
raphy (FFA). All of the subjects underwent an ophthalmic
examination including visual acuity assessment, biomicro-
scopy, air-puff tonometer, indirect retinoscopy, pachymeter,
and macular optical coherence tomography before their par-
ticipation in the study. Exclusion criteria were any ocular sur-
gery other than phacoemulsification, corneal irregularities,
history of glaucoma, uveitis, and any other retinal disorders
except NPDRP. Also, the patients who had nausea and vom-
iting after FFA were excluded, since these situations could
affect theOPAand IOP. Patients had refractive errors between
−1.50 and +1.50 diopters spherical equivalent.
2.2. Measurement Techniques. FFAmeasurements were done
with Topcon TRC 501X angiography (Topcon Corporation,
Tokyo, Japan). FFA procedure was done as follows. 5mL 10%
fluorescein sodiumwas injected rapidly frommedian antecu-
bital vein or dorsal hand veins. After injection, serial retinal
photographs were taken for 5minutes. Between postinjection
5 and 10 minutes, IOP and OPA were measured. In order to
separate the effect of rapid photography from fluorescein
sodium injection, we had taken immediate postcolored reti-
nal photography OPA and IOP measurements of 10 eyes
before the dye injection.
Intraocular pressure (IOP) and ocular pulse amplitude
(OPA) measurements were done with the Pascal dynamic
contour tonometer (Pascal DCT, Swiss Microtechnology
AG, Port, Switzerland). This is a slit-lamp biomicroscopy
mounted, self-calibrating, 7mm tip diameter, and 1.2mm
pressure sensor diameter device. One drop of Alcaine (pro-
paracaine chloride 5mg/mL; Alcon, Fort Worth, TX) was
instilled just prior to IOP and OPA measurements. Measure-
ments were performed within a 5-minute period.Three DCT
measurements were taken in order to have one good-quality
measurement. Only quality 1 and 2measurements were taken
into consideration. All OPA and IOP measurements were
performed by the same investigator (GP) before and after 5
minutes from fluorescein dye injection.
Optical coherence tomography (OCT) measurements
were done with spectral-domain OCT (Spectralis, Heidel-
berg, Germany). Only centralmacular thickness was assessed
by OCT. Corneal pachymetry measurements were done with
Nidek UP-1000 ultrasonic pachymeter and central corneal
thickness was recorded.The pachymeter probe was placed on
the center of the cornea and the mean of five readings was
calculated.
2.3. Statistical Analysis. Statistical analysis was performed
with SPSS forWindows statistical software version 17.0 (SPSS
Inc. Chicago, IL, USA). All data are written as mean ±
standard deviation (SD). Paired 𝑡-test between pre-FFA and
post-FFA OPAs and IOPs were performed to evaluate the
effect of FFA onOPA and IOP.TheWilcoxon signed-rank test
was used to analyze pre- and postretinal photography OPA
and IOP values of 10 eyes. Age and macular thickness were
assessed for a relationship with pre-FFA and post-FFA OPA
and IOP differences using univariate linear regression anal-
ysis. The effects of lens status and gender on pre-FFA and
post-FFA OPA and IOP differences were analyzed with
independent samples 𝑡-test.
3. Results
The study evaluated 30 nonproliferative diabetic retinopathy
patients (15 males, 15 females). Bilateral eyes were recruited
for all the patients. The distribution of eyes according to
NPDRP severitywas as follows:mildNPDRP in 10 eyes,mod-
erate NPDRP in 38 eyes, and severe NPDRP in 12 eyes.
Pre-FFA mean OPA value was 3.05 ± 1.36 (range: 1.40–
7.60, median: 2.60) mmHg and post-FFA mean OPA value
was 2.93 ± 1.28 (range: 1.10–7.00, median: 2.60) mmHg (𝑃 =
0.071). Pre-FFA mean IOP value was 17.97 ± 1.99 (range:
12.80–23.40, median: 18.10) mmHg and post-FFA mean IOP
value was 17.81 ± 2.22 (range: 12.20–24.10, median: 17.80)
mmHg (𝑃 = 0.407). Best corrected visual acuity values
evaluated with Snellen chart ranged between 0.1 and 0.9 in
decimals (mean 0.54 ± 0.28).
In order to evaluate the individual effect of successive
retinal photography, we recorded post-photographyOPA and
IOP values of only ten eyes. Pre-retinal photography mean
OPA value was 2.70 ± 0.66mmHg and postretinal photogra-
phy mean OPA value was 2.63 ± 0.61mmHg (𝑃 = 0.45). Pre-
retinal photography mean IOP value was 18.36± 1.49mmHg
and postretinal photography mean IOP value was 18.28 ±
1.99mmHg (𝑃 = 0.78).
No adverse effects like allergic skin rush or anaphylaxis
occurred after intravenous fluorescein dye injection. Some
demographic and clinical characteristics of the subjects stud-
ied, including mean age, gender, lens status, central cor-
neal thickness, and central macular thickness, are shown in
Table 1.
When considered alone, age (𝑃 = 0.017; 𝑅2 = 0.094)
showed statistically significant association with pre-FFA and
post-FFA OPA difference, while macular thickness (𝑃 =
0.119; 𝑅2 = 0.074) did not show significant association with
OPA change.
Age (𝑃 = 0.001; 𝑅2 = 0.166) showed statistically signifi-
cant association with pre-FFA and post-FFA IOP difference,
while macular thickness (𝑃 = 0.421; 𝑅2 = 0.020) did not
show significant association with IOP difference.
In males, mean OPA value increased 0.093mmHg;
whereas in females, mean OPA value decreased 0.330mmHg
after FFA (𝑃 = 0.001). In males, mean IOP value decreased
by 0.027mmHg and in females mean IOP value decreased by
0.317mmHg (𝑃 = 0.468).
In phakic eyes, mean OPA value decreased by
0.058mmHg and in pseudophakic eyes, mean OPA value
decreased by 0.300mmHg (𝑃 = 0.101). In phakic eyes, mean
IOP value decreased by 0.10mmHg and in pseudophakic
eyes, mean IOP value decreased by 0.38mmHg (𝑃 = 0.548).
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Table 1: Demographic and clinical characteristics of patients stud-
ied.
Age (years ± SD)









(𝜇m ± SD) 551.93 ± 30.97
Central macular thickness
(𝜇m ± SD) 357.41 ± 109.03
4. Discussion
FFAuses intravenous fluorescein dye in order to image retinal
and choroidal circulation. It has become the gold standard
technique in revealing many of the retinal diseases [8]. Since
fluorescein molecule is relatively small, in a normal eye, it
remains within retinal vessels but freely passes the walls
of choroidal vessels [8]. In a diseased retina like diabetic
retinopathy, fluorescein dye also crosses retinal vessels.There
are many fluorescein derivatives and fluorescein sodium is
used in FFA. There is lack of comprehensive data about the
effects of fluorescein sodium and FFA procedure on ocular
tissues. In this study, we examined IOP and OPA only in
diabetic retinopathy, although there are many other ocular
tissues, functions, and disorders that may be affected by FFA
procedure.
Possible factors related to FFA procedure that may affect
ocular tissues and functions are not clear. But, the amount
of injected fluid, the fluorescein leakage both in diseased
retinal vessels and choroid, anxiety of patients related to
the examination, the effect of sequential photograph taking,
and/or the fluorescence ability of injected molecule might
affect IOP and OPA. But more probable factors are the
osmotic effects and hemorheological effects of fluorescein
sodium. We did not have the opportunity to investigate
individual contribution of these factors, but we take into
consideration FFA procedure in general.
Sargento et al. in their study about sodium fluorescein
influence on the hematological properties of diabetic patients,
revealed that sodium fluorescein injection during retinogra-
phy increased whole blood viscosity, erythrocyte elongation
index, blood pH, carboxyhemoglobin, and methemoglobin
levels and caused a sudden structural or functional reduction
of red cell acetylcholinesterase activity [9]. All of these factors
might have an effect on choroidal blood flow and hence
ocular pulse amplitude.
Another possible mechanism about sodium fluorescein
effect on OPA might be the osmotic effect, since Fluorescite
10% has an osmolality of 572–858mOsm/kg and plasma has
an osmolality of 285–295mOsm/kg. It is known that small
changes in osmolality can have a marked effect on water
transfer [10]. However, it was reported that 30 minutes after
sodium fluorescein injection, the increase in plasma osmolal-
ity was statistically insignificant [9].
In this study, although both mean OPA and IOP values
were decreased after FFA procedure, the difference was not
statistically significant. But FFA procedure affectedmales and
females differently in the aspect of OPA. Mean OPA value
of males increased, whereas mean OPA value of females
decreased after FFA. Possible explanation about this result
might be the effects of gender on FFA procedure and OPA,
since gender differences in health issues could be seen.
In the literature, various factors affectingOPAwere inves-
tigated. Some of the factors that decrease OPA are carotid
artery stenosis, accommodation, glaucoma, scleral buckling
surgery, regional orbital anesthesia, Graves’ ophthalmopa-
thy, panretinal photocoagulation, physical exercise, diurnal
variation (lowest OPA at 1:00–3:00 pm), advanced retinitis
pigmentosa, and exudative age-related macular degeneration
[11–21]. Some factors that does not alter OPA are smoking,
intravitreal bevacizumab injection, trabeculectomy, valsalva
maneuver, and systemic blood pressure [3, 22–25]. Some fac-
tors that increase OPA are water drinking and high IOP
[26, 27]. Since OPA is accepted as an indirectmeasurement of
choroidal blood flow and fluorescein dye freely passes from
choroidal vessels into the extravasal space, we thought that
FFA might have an influence on OPA.
Centofanti et al. investigated influence of sex and hor-
monal status on choroidal blood flow [28]. They used ocular
blood flow tonograph to measure OPA. They found that
premenopausal females (age: 17–42 years) had significantly
higher rates ofOPAwhen comparedwith age-matchedmales,
whereas postmenoposal females (age: >55 years) had similar
OPA values with age-matched males. They concluded this
result might be due to hormonal status (oestrogen) [28]. Our
female study group was generally composed of postmeno-
posal females. In our study, the difference between males and
females was not based on mean OPA value; it was due to
the different influence of FFA procedure on OPA between
genders. Althoughwe could not explain the exactmechanism
of this result, it is known that gender influences occurrence
and outcome of some disorders [29]. Also, we measured that
pre-FFA and post-FFA mean IOP difference was higher in
females than in males. Since IOP affects OPA, this might
also explain different OPAmeasurements between males and
females.
Schmidt et al. examined OPA in diabetes mellitus and
reported that choroidal circulation remained unaffected as
diabetic retinopathy advanced [30]. Their study group was
composed of diabetic patients in three subgroups: no diabetic
retinopathy, NPDRP, and proliferativeDRP. In our study, only
NPDRP patients were included into the study in order to
maintain better homogeneity.We also examined the effects of
fluorescein leakage amount in terms ofmacular thickness and
found that it had no significant effect on OPA and IOP.
There are some restrictions related to this study. For
example, ideal timing of OPA and IOP measurements after
FFA is difficult to determine. Since taking photographs is very
important in the first five minutes, it was not appropriate
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to disturb the examination. But we quickly measured OPA
and IOP after 5 minutes from fluorescein injection. We did
not performFFAon normal subjects, but in order tomaintain
standardization of the patients, only NPDRP patients were
included in the study. One may say if there were an issue, 50
years and millions of fluorescein angiograms later, we would
have learned of it. But, according to us, it is important to
document these data about FFA for the first time in the
literature.
In conclusion, FFA procedure does not affect OPA and
IOP values. But, age showed significant association with pre-
FFA and post-FFA OPA and IOP differences. Interestingly,
mean OPA value of males increased, whereas mean OPA
value of females decreased after FFA. More comprehensive
studies including various ocular and systemic diseases and
measurements at different FFA stages are needed to reveal
more effects of FFA on OPA.
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